Forecast & Rating4 analysts currently cover OS Therapies, of which 4 give a positive rating. The average price target is $8.50, about 352.1% upside from the current price of $1.88. Coverage is limited, so the data is for reference only. Data as of Sep 4, 2026; this does not constitute investment advice.
Sep 4, 2026Price forecast
$8.50352.13%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 31, 2026
Forecast met0.0%
Stock price$1.88
Avg. target$8.9
High target$13
Low target$6
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.